GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Retained Earnings

Australian Clinical Labs (ASX:ACL) Retained Earnings : A$146.2 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Australian Clinical Labs's retained earnings for the quarter that ended in Dec. 2023 was A$146.2 Mil.

Australian Clinical Labs's quarterly retained earnings declined from Dec. 2022 (A$158.9 Mil) to Jun. 2023 (A$155.2 Mil) and declined from Jun. 2023 (A$155.2 Mil) to Dec. 2023 (A$146.2 Mil).

Australian Clinical Labs's annual retained earnings increased from Jun. 2021 (A$62.2 Mil) to Jun. 2022 (A$216.2 Mil) but then declined from Jun. 2022 (A$216.2 Mil) to Jun. 2023 (A$155.2 Mil).


Australian Clinical Labs Retained Earnings Historical Data

The historical data trend for Australian Clinical Labs's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Retained Earnings Chart

Australian Clinical Labs Annual Data
Trend Dec20 Jun21 Jun22 Jun23
Retained Earnings
- 62.19 216.22 155.24

Australian Clinical Labs Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Retained Earnings Get a 7-Day Free Trial 192.41 216.22 158.91 155.24 146.25

Australian Clinical Labs Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Australian Clinical Labs  (ASX:ACL) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Australian Clinical Labs (ASX:ACL) Business Description

Traded in Other Exchanges
N/A
Address
1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168
Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines